Skip to main content
David Herrmann, MD, Neurology, Rochester, NY

David N Herrmann MD

Neuromuscular Medicine, Neurophysiology


Professor, Neurology, Chief, Neuromuscular Division, University of Rochester School of Medicine & Dentistry

Join to View Full Profile
  • 601 Elmwood AveRochester, NY 14642

  • Phone+1 585-275-4568

  • Fax+1 585-273-1254

Dr. Herrmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Clinical Neurophysiology, 1998 - 1999
  • University of Michigan
    University of MichiganResidency, Neurology, 1995 - 1998
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1999 - 2026
  • GA State Medical License
    GA State Medical License 2014 - 2015
  • MI State Medical License
    MI State Medical License 1994 - 2001
  • Neurology
    American Board of Psychiatry and Neurology Neurology
  • Clinical Neurophysiology
    American Board of Psychiatry and Neurology Clinical Neurophysiology
  • Neuromuscular Medicine
    American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Peripheral Sensory Pathology Seen in Autism Spectrum Disorder
    Peripheral Sensory Pathology Seen in Autism Spectrum DisorderOctober 15th, 2020
  • CMT1A Patients Needed for Study Seeking New Ways to Monitor Disease Progression
    CMT1A Patients Needed for Study Seeking New Ways to Monitor Disease ProgressionSeptember 15th, 2020
  • Regenacy Pharmaceuticals Announces Collaboration with the Charcot-Marie-Tooth Association (CMTA) to Advance Ricolinostat for the Treatment of Hereditary Neuropathy
    Regenacy Pharmaceuticals Announces Collaboration with the Charcot-Marie-Tooth Association (CMTA) to Advance Ricolinostat for the Treatment of Hereditary NeuropathyAugust 2nd, 2018
  • Join now to see all

Grant Support

  • Accelerate Clinical Trials in CMT (ACTCMT) StudyUNIVERSITY OF ROCHESTER2019–2025
  • In-Vivo Confocal Imaging Of Meissner'S Corpuscles As A Measure Of HIV NeuropathyNational Institute Of Neurological Disorders And Stroke2007–2008
  • Epidermal Innervation As An Outcome MeasureNational Institute Of Neurological Disorders And Stroke2002–2006

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: